je.st
news
Home
› Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates
Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates
2013-04-12 09:19:56| drugdiscoveryonline News Articles
Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a number of new drug candidates
Tags: agreement
develop
drug
identify
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||